抗病毒治疗-话题@MedSci

#抗病毒治疗#

121篇内容 | 5067人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1292862, encodeId=3c0312928620d, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Ann Surg：抗病毒治疗可降低HBV-DNA水平低的患者的肝细胞癌复发, objectType=article, longId=155874, objectId=e0181558e4e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0181558e4e7, replyNumber=0, likeNumber=96, createdTime=2018-12-17, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0181558e4e7, moduleTitle=Ann Surg：抗病毒治疗可降低HBV-DNA水平低的患者的肝细胞癌复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0181558e4e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292861, encodeId=20d01292861d8, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=惨痛的代价/慢性乙肝的抗病毒治疗需要规范管理, objectType=article, longId=154463, objectId=0d6215446319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d6215446319, replyNumber=0, likeNumber=86, createdTime=2018-11-28, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d6215446319, moduleTitle=惨痛的代价/慢性乙肝的抗病毒治疗需要规范管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d6215446319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292860, encodeId=6b71129286074, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=NMPA：慢性乙型肝炎抗病毒治疗药物临床试验技术指导原则（2018年第29号）, objectType=article, longId=152966, objectId=6bf3152966e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bf3152966e3, replyNumber=0, likeNumber=84, createdTime=2018-11-09, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bf3152966e3, moduleTitle=NMPA：慢性乙型肝炎抗病毒治疗药物临床试验技术指导原则（2018年第29号）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bf3152966e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292859, encodeId=221912928595f, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Gastroenterology：Glecaprevir联合Pibrentasvir治疗对既往直接抗病毒治疗失败的慢性丙型肝炎患者的实际疗效分析, objectType=article, longId=151478, objectId=14541514e895, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14541514e895, replyNumber=0, likeNumber=55, createdTime=2018-10-22, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14541514e895, moduleTitle=J Gastroenterology：Glecaprevir联合Pibrentasvir治疗对既往直接抗病毒治疗失败的慢性丙型肝炎患者的实际疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14541514e895)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292858, encodeId=252312928585e, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Hepatol：在抗病毒治疗期间，ALT水平正常与慢性乙型肝炎患者肝脏事件的风险降低有关, objectType=article, longId=149273, objectId=5fe91492e39e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fe91492e39e, replyNumber=0, likeNumber=88, createdTime=2018-09-22, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fe91492e39e, moduleTitle=J Hepatol：在抗病毒治疗期间，ALT水平正常与慢性乙型肝炎患者肝脏事件的风险降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fe91492e39e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292857, encodeId=a8c6129285ef3, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Hepatol：在HCV患者抗病毒治疗后，开发出一种可以患者发生HCC风险的模型, objectType=article, longId=147741, objectId=96b614e7416e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96b614e7416e, replyNumber=0, likeNumber=97, createdTime=2018-08-31, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96b614e7416e, moduleTitle=J Hepatol：在HCV患者抗病毒治疗后，开发出一种可以患者发生HCC风险的模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96b614e7416e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292856, encodeId=dc7112928566a, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=JAMA Surg：肝切除前抗病毒治疗能降低早期复发风险？, objectType=article, longId=147528, objectId=b2e714e52840, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2e714e52840, replyNumber=0, likeNumber=148, createdTime=2018-08-29, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2e714e52840, moduleTitle=JAMA Surg：肝切除前抗病毒治疗能降低早期复发风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2e714e52840)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292855, encodeId=48cb129285515, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=病毒阴性的肝硬化需要抗病毒治疗吗？, objectType=article, longId=145833, objectId=d21414583350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d21414583350, replyNumber=0, likeNumber=45, createdTime=2018-08-05, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d21414583350, moduleTitle=病毒阴性的肝硬化需要抗病毒治疗吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d21414583350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292854, encodeId=4e381292854ea, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=丙肝抗病毒治疗与血液透析，如何取得双赢的局面？, objectType=article, longId=141391, objectId=6db1141391dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6db1141391dd, replyNumber=0, likeNumber=62, createdTime=2018-06-24, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6db1141391dd, moduleTitle=丙肝抗病毒治疗与血液透析，如何取得双赢的局面？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6db1141391dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292853, encodeId=5ee1129285379, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Aliment Pharmacol Ther：抗病毒治疗可提高乙肝病毒相关肝细胞癌患者的生存率, objectType=article, longId=140424, objectId=6c87140424b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c87140424b8, replyNumber=0, likeNumber=128, createdTime=2018-06-11, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c87140424b8, moduleTitle=Aliment Pharmacol Ther：抗病毒治疗可提高乙肝病毒相关肝细胞癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c87140424b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292852, encodeId=140f129285285, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Gastroenterol Hepatol：乙肝病毒S基因整合对抗病毒治疗患者乙肝表面抗原水平的影响, objectType=article, longId=140405, objectId=54881404052f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54881404052f, replyNumber=0, likeNumber=94, createdTime=2018-06-11, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54881404052f, moduleTitle=J Gastroenterol Hepatol：乙肝病毒S基因整合对抗病毒治疗患者乙肝表面抗原水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54881404052f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292851, encodeId=e76212928516f, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Journal of Clinical Gastroenterology：溃疡性结肠炎患者结肠巨细胞病毒感染的抗病毒治疗显着提高了其手术无生存率, objectType=article, longId=139692, objectId=7abe13969219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7abe13969219, replyNumber=0, likeNumber=76, createdTime=2018-06-03, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7abe13969219, moduleTitle=Journal of Clinical Gastroenterology：溃疡性结肠炎患者结肠巨细胞病毒感染的抗病毒治疗显着提高了其手术无生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7abe13969219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292850, encodeId=2a7212928501a, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=乙肝抗病毒治疗：你需要了解的四个关键点, objectType=article, longId=139485, objectId=cc2813948537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc2813948537, replyNumber=0, likeNumber=79, createdTime=2018-06-01, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc2813948537, moduleTitle=乙肝抗病毒治疗：你需要了解的四个关键点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc2813948537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292849, encodeId=e2cb12928495d, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Eur J Gastroenterol Hepatol：在意大利口服直接抗病毒治疗时代之前，丙型肝炎病毒相关慢性肝病患者的特点, objectType=article, longId=139296, objectId=a7b7139296b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7b7139296b0, replyNumber=0, likeNumber=58, createdTime=2018-05-29, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7b7139296b0, moduleTitle=Eur J Gastroenterol Hepatol：在意大利口服直接抗病毒治疗时代之前，丙型肝炎病毒相关慢性肝病患者的特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7b7139296b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292848, encodeId=62fd1292848f3, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Liver Int：HCV患者在接受直接抗病毒治疗过程中，HBV再激活的风险, objectType=article, longId=138064, objectId=bdd0138064e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdd0138064e2, replyNumber=0, likeNumber=66, createdTime=2018-05-15, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdd0138064e2, moduleTitle=Liver Int：HCV患者在接受直接抗病毒治疗过程中，HBV再激活的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdd0138064e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292847, encodeId=ce43129284e25, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Viral Hepat：抗病毒治疗后获得病毒抑制的慢性乙型肝炎患者与非活性期慢性乙型肝炎患者间整体存活率的比较, objectType=article, longId=137872, objectId=094213e872ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=094213e872ba, replyNumber=0, likeNumber=66, createdTime=2018-05-12, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=094213e872ba, moduleTitle=J Viral Hepat：抗病毒治疗后获得病毒抑制的慢性乙型肝炎患者与非活性期慢性乙型肝炎患者间整体存活率的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=094213e872ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292846, encodeId=597812928466a, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Radiology：抗病毒治疗在延缓慢性乙肝肝硬化进展的作用有多大呢？, objectType=article, longId=136297, objectId=13eb13629ed7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13eb13629ed7, replyNumber=0, likeNumber=84, createdTime=2018-04-25, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13eb13629ed7, moduleTitle=Radiology：抗病毒治疗在延缓慢性乙肝肝硬化进展的作用有多大呢？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13eb13629ed7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292845, encodeId=d3291292845f3, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Hepatol：HepCom评分，在启动直接抗病毒治疗后，可以检测出高危人群以及相关的临床事件, objectType=article, longId=136264, objectId=b4b31362646f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4b31362646f, replyNumber=0, likeNumber=68, createdTime=2018-04-25, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4b31362646f, moduleTitle=J Hepatol：HepCom评分，在启动直接抗病毒治疗后，可以检测出高危人群以及相关的临床事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4b31362646f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292844, encodeId=9c4c129284471, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Infect Dis：我国学者揭示人感染H7N9禽流感病毒排毒时间的独立危险因素：延迟抗病毒治疗和应用糖皮质激素, objectType=article, longId=135788, objectId=2353135e889a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2353135e889a, replyNumber=0, likeNumber=78, createdTime=2018-04-20, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2353135e889a, moduleTitle=J Infect Dis：我国学者揭示人感染H7N9禽流感病毒排毒时间的独立危险因素：延迟抗病毒治疗和应用糖皮质激素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2353135e889a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292843, encodeId=fecb1292843ae, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Gastroenterol Hepatol：sCD163和sMR与CHB患者的组织学炎症活动度和纤维化有关；抗病毒治疗后，两者水平均降低, objectType=article, longId=135179, objectId=35111351e931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35111351e931, replyNumber=0, likeNumber=72, createdTime=2018-04-14, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35111351e931, moduleTitle=J Gastroenterol Hepatol：sCD163和sMR与CHB患者的组织学炎症活动度和纤维化有关；抗病毒治疗后，两者水平均降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35111351e931)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗病毒治疗

2020-05-29

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Ann Surg：抗病毒治疗可降低HBV-DNA水平低的患者的肝细胞癌复发

2018-12-17

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

惨痛的代价/慢性乙肝的抗病毒治疗需要规范管理

2018-11-28

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

NMPA：慢性乙型肝炎抗病毒治疗药物临床试验技术指导原则（2018年第29号）

2018-11-09

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Gastroenterology：Glecaprevir联合Pibrentasvir治疗对既往直接抗病毒治疗失败的慢性丙型肝炎患者的实际疗效分析

2018-10-22

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Hepatol：在抗病毒治疗期间，ALT水平正常与慢性乙型肝炎患者肝脏事件的风险降低有关

2018-09-22

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Hepatol：在HCV患者抗病毒治疗后，开发出一种可以患者发生HCC风险的模型

2018-08-31

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

JAMA Surg：肝切除前抗病毒治疗能降低早期复发风险？

2018-08-29

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

病毒阴性的肝硬化需要抗病毒治疗吗？

2018-08-05

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

丙肝抗病毒治疗与血液透析，如何取得双赢的局面？

2018-06-24

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Aliment Pharmacol Ther：抗病毒治疗可提高乙肝病毒相关肝细胞癌患者的生存率

2018-06-11

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Gastroenterol Hepatol：乙肝病毒S基因整合对抗病毒治疗患者乙肝表面抗原水平的影响

2018-06-11

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Journal of Clinical Gastroenterology：溃疡性结肠炎患者结肠巨细胞病毒感染的抗病毒治疗显着提高了其手术无生存率

2018-06-03

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

乙肝抗病毒治疗：你需要了解的四个关键点

2018-06-01

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Eur J Gastroenterol Hepatol：在意大利口服直接抗病毒治疗时代之前，丙型肝炎病毒相关慢性肝病患者的特点

2018-05-29

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Liver Int：HCV患者在接受直接抗病毒治疗过程中，HBV再激活的风险

2018-05-15

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Viral Hepat：抗病毒治疗后获得病毒抑制的慢性乙型肝炎患者与非活性期慢性乙型肝炎患者间整体存活率的比较

2018-05-12

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Radiology：抗病毒治疗在延缓慢性乙肝肝硬化进展的作用有多大呢？

2018-04-25

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Hepatol：HepCom评分，在启动直接抗病毒治疗后，可以检测出高危人群以及相关的临床事件

2018-04-25

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Infect Dis：我国学者揭示人感染H7N9禽流感病毒排毒时间的独立危险因素：延迟抗病毒治疗和应用糖皮质激素

2018-04-20

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Gastroenterol Hepatol：sCD163和sMR与CHB患者的组织学炎症活动度和纤维化有关；抗病毒治疗后，两者水平均降低

2018-04-14

科室
- - 订阅+
  - 更多科室
工具
服务